Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. IOSP
stocks logo

IOSP

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Financial AI Agent
Financial AI Agent

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
460.87M
-1.27%
1.240
-12.06%
461.75M
+4.75%
1.400
-1.41%
465.50M
+5.87%
1.345
+6.75%
Estimates Revision
The market is revising Downward the revenue expectations for Innospec Inc. (IOSP) for FY2025, with the revenue forecasts being adjusted by -1.09% over the past three months. During the same period, the stock price has changed by -13.66%.
Revenue Estimates for FY2025
Revise Downward
down Image
-1.09%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-2.95%
In Past 3 Month
Stock Price
Go Down
down Image
-13.66%
In Past 3 Month
Wall Street analysts forecast IOSP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IOSP is 93.00 USD with a low forecast of 93.00 USD and a high forecast of 93.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast IOSP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IOSP is 93.00 USD with a low forecast of 93.00 USD and a high forecast of 93.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 74.010
sliders
Low
93.00
Averages
93.00
High
93.00
Current: 74.010
sliders
Low
93.00
Averages
93.00
High
93.00
Freedom Capital
initiated
$93
2025-11-17
Reason
Freedom Capital
Price Target
$93
2025-11-17
initiated
Reason
Freedom Capital initiated coverage of Innospec with a Buy rating and $93 price target, calling the company an "undervalued" specialty chemicals maker. The firm said it sees potential upside from either new product offerings or opportunistic M&A. Freedom Capital noted that the stock's recent underperformance along with its bottoming earnings "create an attractive risk-reward tradeoff."
Seaport Global
Michael Harrison
Hold
to
Strong Buy
Upgrades
$155
2025-04-21
Reason
Seaport Global
Michael Harrison
Price Target
$155
2025-04-21
Upgrades
Hold
to
Strong Buy
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for Innospec Inc (IOSP.O) is 14.03, compared to its 5-year average forward P/E of 17.85. For a more detailed relative valuation and DCF analysis to assess Innospec Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PE
17.85
Current PE
14.03
Overvalued PE
20.40
Undervalued PE
15.29

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
10.92
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
12.53
Undervalued EV/EBITDA
9.31

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.39
Current PS
0.00
Overvalued PS
1.60
Undervalued PS
1.19
Intellectia AI SwingMax
Intellectia AI SwingMax

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

IOSP News & Events

Events Timeline

(ET)
2025-08-05
17:28:16
Innospec reports Q2 EPS 94c, consensus $1.21
select
2025-03-10 (ET)
2025-03-10
16:46:38
Innospec approves new $50M share buyback program
select
2025-03-03 (ET)
2025-03-03
09:12:48
Innospec expands production of drag reducing agents
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
4.0
12-04NASDAQ.COM
Fresh Strong Sell Stocks for December 4th

  • Stocks Added to Zacks Rank #5: Boise Cascade Company, Eastman Chemical Company, and Innospec Inc. have been added to the Zacks Rank #5 (Strong Sell) List due to significant downward revisions in their earnings estimates over the past 60 days.

  • Earnings Estimate Revisions: Boise Cascade's earnings estimate was revised down by 17.9%, Eastman Chemical's by 6.6%, and Innospec's by 5.6% for the current year.

  • Top Stock Recommendations: Zacks Investment Research has revealed their Top 5 stock recommendations, highlighting one that could significantly outperform previous successful picks.

  • Access to Stock Analysis Reports: Free stock analysis reports for Eastman Chemical, Boise Cascade, and Innospec are available for those interested in further insights.

[object Object]
Preview
6.0
11-18Benzinga
Lumentum Analyst Starts Coverage Optimistically; Check Out Tuesday's Top 5 Initiations

  • Analyst Coverage Initiations: Several Wall Street analysts have initiated coverage on various companies, providing new ratings and price targets for investors to consider.

  • Kestra Medical Technologies: BTIG analyst Marie Thibault rated Kestra Medical Technologies Ltd (KMTS) as a Buy with a price target of $32, while the stock closed at $25.10.

  • Innospec Inc: Freedom Capital Markets analyst David Silver also rated Innospec Inc (IOSP) as a Buy, setting a price target of $93, with shares closing at $72.23.

  • Other Notable Ratings: UBS's Michael Goldsmith rated Sabra Health Care REIT Inc (SBRA) as Neutral with a $20 target, while Mizuho's Vijay Rakesh rated Lumentum Holdings Inc (LITE) as Outperform with a $290 target.

[object Object]
Preview
4.0
11-18Benzinga
Freedom Capital Markets Begins Coverage of Innospec with a Buy Rating and Sets Price Target at $93

  • Real-time Intelligence: Benzinga Pro offers the fastest news alerts for traders to stay updated on market movements.

  • Exclusive Content: The platform provides exclusive stories and insights generated by Benzinga reporters for its users.

  • Community Engagement: Over 10,000 serious traders are part of the Benzinga Pro community, enhancing collaboration and information sharing.

  • Market Winning Tools: Traders utilize Benzinga Pro's tools and intelligence to improve their trading strategies and outcomes.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Innospec Inc (IOSP) stock price today?

The current price of IOSP is 74.01 USD — it has decreased -1.12 % in the last trading day.

arrow icon

What is Innospec Inc (IOSP)'s business?

Innospec Inc. develops, manufactures, blends, markets, and supplies a wide range of specialty chemicals to customers in the Americas, Europe, the Middle East, Africa, and Asia-Pacific. The Company operates through three segments: Performance Chemicals, Fuel Specialties and Oilfield Services. The Company’s Performance Chemicals business creates technology-based solutions for the personal care, home care, agrochemical, construction, mining, and other industrial markets. This segment serves multinational companies, manufacturers of personal care and home care products and global mining, agricultural and building products and other industrial companies. The Company’s Fuel Specialties segment develops, manufactures, blends, markets, and supplies a range of specialty chemical products used as additives in diesel, jet, marine, fuel oil and other fuels. The Company’s Oilfield Services business supplies drilling, completion, and production chemicals.

arrow icon

What is the price predicton of IOSP Stock?

Wall Street analysts forecast IOSP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IOSP is 93.00 USD with a low forecast of 93.00 USD and a high forecast of 93.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Innospec Inc (IOSP)'s revenue for the last quarter?

Innospec Inc revenue for the last quarter amounts to 441.90M USD, decreased -0.34 % YoY.

arrow icon

What is Innospec Inc (IOSP)'s earnings per share (EPS) for the last quarter?

Innospec Inc. EPS for the last quarter amounts to 0.52 USD, decreased -60.90 % YoY.

arrow icon

What changes have occurred in the market's expectations for Innospec Inc (IOSP)'s fundamentals?

The market is revising Downward the revenue expectations for Innospec Inc. (IOSP) for FY2025, with the revenue forecasts being adjusted by -1.09% over the past three months. During the same period, the stock price has changed by -13.66%.
arrow icon

How many employees does Innospec Inc (IOSP). have?

Innospec Inc (IOSP) has 2450 emplpoyees as of December 05 2025.

arrow icon

What is Innospec Inc (IOSP) market cap?

Today IOSP has the market capitalization of 1.85B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free